• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Technology Events 2026-2027
  • Sponsored Post
  • Technology Markets
  • About
    • GDPR
  • Contact

Enveda Raises $311M Series E, Doubling Its Valuation to $2 Billion for AI-Discovered Medicines From Nature

September 24, 2026 By admin

Enveda, a Boulder, Colorado drug developer, has raised $311 million in a Series E that doubles its valuation to $2 billion. Catalio Capital Management led the round. New investors include Durable Capital Partners, ICONIQ, Lightspeed, Surveyor Capital (a Citadel company), T. Rowe Price, Digitalis Ventures and Alderline Group. Baillie Gifford, Premji Invest, Kinnevik, Lux Capital and other existing backers came back in. Enveda has now raised more than $845 million.

Its thesis is old and new at once. Many important drugs, aspirin and morphine among them, came from plants and microbes. The trouble has always been that nature’s chemistry is enormous and mostly uncharted. “The most reliable source of new medicines is the chemistry that living things have been refining for billions of years,” says founder and CEO Viswa Colluru.

PRISM, the mapping engine

Enveda’s platform is called PRISM. It’s an AI foundation model that works from mass spectrometry data. It identifies bioactive molecules in natural samples, predicts their structures and ranks them by how likely they are to become a therapy. Since 2019 it has produced 17 development candidates. That’s a fast pace for a company making small-molecule drugs from scratch.

Three drugs in the clinic

  • ENV-294 for atopic dermatitis (eczema) and asthma, now moving into Phase 2 after strong Phase 1b results.
  • ENV-308 for metabolic health and weight management, with Phase 1 complete.
  • ENV-6946 for inflammatory bowel disease, in Phase 1.

The new money pushes those three into later-stage trials. It also brings more candidates into the clinic for inflammatory and metabolic disease and expands PRISM itself. Most AI drug discovery companies are still waiting on their first clinical proof. Enveda has three shots on goal already, and investors just paid up for that.

Filed Under: News

Footer

Recent Posts

  • Saltgrain and NTT Research Show Post-Quantum Attribute-Based Encryption Fast Enough for a Laptop
  • Quantum Moves Into the Supercomputer Queue as IQM, Altera and Infleqtion Report Progress
  • Penguin Solutions and Marvell Bet on Photonics to Break the GPU Memory Wall
  • TensorWave Signs Six-Year Deal to Supply OpenAI With 457MW of AMD Helios Capacity
  • LangChain Raises $300 Million at a $3 Billion Valuation to Build Out LangSmith Agent Platform
  • OQFT Shows Where the Quantum Fourier Transform Can Get Shallower
  • MemryX MX3+ Targets 1 POPS for Edge AI as Tianji Shows a 21-Joint Robot Hand at CoRL and Appear Starts Solid-State Battery Pre-Production
  • Adobe MAX 2026 Opens Photoshop and Premiere to Outside AI Agents and Deepens Its Google Partnership
  • Zendesk Launches Outcome AI Platform and Drops Seat Limits From New Plans
  • Otto One Is a $599 Screenless Computer Built for an AI Agent to Live On

Media Partners

  • Market Analysis
  • BareProxy.com
  • App Coding
Hormuz Risk Gauge Falls to 63.8 High as the Dubai Premium Vanishes While Tanker Attacks Keep Coming
China Turns AI Model Distillation Into Industrial Policy and Weakens the Reach of US Chip Controls
AI-Found Software Flaws and the Rush to Patch Them Are Now a Market Risk After a Week of US Outages
Ohio Voters Put $17 Billion of Amazon Data Center Spending at Risk as Local Bans Spread
US Remote Access Chip Rule and FCC Optics Ban Squeeze Southeast Asia Data Centers and Nvidia China Exposure
Microsoft Puts Word, Excel and PowerPoint Inside Copilot and Turns Office Into an AI Front Door
OpenAI Cuts GPT-6.2 Astra Prices 20% as Microsoft MAI Code 2 Undercuts Frontier Coding Models
Tencent Q3 Shows New AI Products Cost About RMB15 Billion in Operating Profit as Capex Hits 39% of Revenue
Anthropic IPO Heads for the Top of Its Range as $900 Billion in Compute Commitments Go Public
Nvidia Q3 Revenue Hits $115.8 Billion but the Q4 Margin Guide Drops Three Points as the Board Rules Out Jensen Huang
BareProxy Adds AI Crawler Control That Tells Real GPTBot and ClaudeBot Requests From Fakes
BareProxy Adds Bot Challenges That Make Scrapers Posing as Browsers Solve a Puzzle First
BareProxy Adds Cookie Consent That Holds Back Tracking Cookies Until a Visitor Says Yes
BareProxy Adds Markdown Serving That Turns Markdown Files Into Web Pages With No Build Step
BareProxy Ships Its First Nine Plugins, From Maintenance Pages and CORS to Geo Rules and Rate Limits
BareProxy 0.2.0 Runs WebAssembly Plugins Through the Proxy-Wasm Interface
BareProxy 0.3.0 Writes Its Plugins in Rust, Where a Plugin Adds 15 Microseconds Instead of 42
BareProxy Is an Operating System for Web Traffic: A Small Core and a Long Stream of Plugins
BareProxy Plugins Go WebAssembly, Starting With RenderCache and AI Crawler Control
BareProxy Runs on Linux, macOS and Windows, and One Plugin File Runs on All of Them
Testing Optimistic Quantum Fourier Transform Circuits With OQFT and Qiskit
Bluehost AI Builder Turns a Prompt Into a Website or a Booking App and Takes the AI App Builder Fight to Hosting Customers
Claude Code on GitLab vs GitHub: Thinner Integration and a Fifth of the Free CI Minutes
How k4i.com Publishes Posts Unattended With Small AI Models, Groq and GitHub Actions
How to Ship In-Browser AI Apps With No Server and No Inference Bill
Microsoft Authenticator Android Flaw Shows Why Apps Must Verify Who Is Calling Them
Zero-Budget AI Apps Work Best as Self-Feeding Sites, Not Open Tools
A Useful Software Primitive Should Be Easy to Explain and Hard to Replace
Apple's US Link-Out Fee Is Zero Until a Judge Sets It, and Apple Is Asking for Up to 15%
20 Primitive Project Ideas: Tiny Go Engines That Do the Essential 10% of Redis, Kafka and Etcd

Media Partners

  • AltSql.com
  • Technology Conferences
  • API Coding
AltSql Is a Native Hybrid of Key-Value and SQL, From the Sensor to the Gateway
AltSql Core and AltSql DB Are Now Open Source Under the Apache License 2.0
Introduction
AltSql DB 0.3 Adds Secondary Indexes and Statement Savepoints: A Lookup on a Million Rows Ran 198 Times Faster Than a Full Scan
How It Works
AltSql DB 0.2: SQL and Direct Calls Wrote Byte-Identical Files Over 100,000 Random Steps
AltSql DB Keeps a Whole Fleet in One File and Reads by Key 5 Times Faster Than SQLite Through SQL
AltSql Core and Six Prototypes Built Around It
AltSql Ask Puts One SQL Question to 500 Simulated Machines and Brings Back Only the Answers
Machine Monitoring Case Study: Overheat Alarm Handled on the Sensor While Wi-Fi Was Down
December 1, 2026 Investor Conferences, UBS Industrials, Evercore Healthcare and Morgan Stanley Consumer and Retail
Morgan Stanley European TMT Conference 2026, November 18-19, Barcelona
Roth Technology Conference 2026, November 17-18, Hard Rock Hotel, New York
Barclays Global Technology Conference 2026, December 9-10, San Francisco
Wells Fargo TMT Summit 2026, December 8, Rancho Palos Verdes
UBS Global Technology and AI Conference 2026, November 30–December 2, Scottsdale
Kinaxis Kinexions India 2026, November 17-18, Mumbai
Tanium Converge 2026, November 16-19, ARIA Resort and Casino, Las Vegas
Aspen Cyber Summit 2026, November 18, Washington DC
Solana Breakpoint 2026, November 15-17, Olympia London, London
RFC 9457 Problem Details Gives API Errors One Shape Instead of Fifty Ad Hoc JSON Bodies
Idempotency Keys: How One Header Stops a Retry From Charging a Customer Twice
A Tiny ETL Binary Competes With curl, jq and SQLite in a Cron Job, So Build It That Small
An AI Agent Flight Recorder Belongs in One Portable File, the Way HAR Did It for HTTP
Benchmarking MCP Servers and Stateful API Workflows: Latency, Throughput and Tokens per Call
Diagnose a Slow API From One Request: DNS, Connect, TLS, Server Wait and Transfer
Finding API Endpoints, Tables and Flags Nobody Uses Takes Code and Traffic Together
Fuzzing MCP Servers: Generate Bad Arguments From the Tool Schema and Watch What Breaks
Give Any API a History: Poll It, Hash It and Query Old Versions With SQL
Infer Your API's Real Contract From Traffic, Then Diff It Against the Docs

Copyright © 2026 Technologies.org

Media Partners: Market Analysis · Market Research · Referently · Photography